NCT00388479View on ClinicalTrials.gov

Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/ Postoperative Ileus

PHASE3CompletedINTERVENTIONAL

Enrollment

666

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions

Ileus

Interventions

DRUG

Alvimopan

Trial Locations (1)

19341

Various, Exton

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY